Roman Butler Fullerton & Co’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$818K Sell
4,300
-270
-6% -$51.4K 0.24% 107
2025
Q1
$808K Buy
4,570
+16
+0.4% +$2.83K 0.31% 79
2024
Q4
$806K Sell
4,554
-207
-4% -$36.6K 0.26% 97
2024
Q3
$913K Buy
4,761
+9
+0.2% +$1.73K 0.27% 89
2024
Q2
$799K Buy
4,752
+7
+0.1% +$1.18K 0.26% 89
2024
Q1
$797K Buy
4,745
+109
+2% +$18.3K 0.3% 85
2023
Q4
$762K Sell
4,636
-59
-1% -$9.7K 0.3% 83
2023
Q3
$695K Buy
4,695
+111
+2% +$16.4K 0.33% 82
2023
Q2
$631K Buy
4,584
+409
+10% +$56.3K 0.29% 91
2023
Q1
$688K Buy
4,175
+118
+3% +$19.5K 0.34% 90
2022
Q4
$620K Buy
4,057
+18
+0.4% +$2.75K 0.32% 92
2022
Q3
$572K Buy
4,039
+8
+0.2% +$1.13K 0.36% 89
2022
Q2
$619K Sell
4,031
-103
-2% -$15.8K 0.34% 87
2022
Q1
$670K Buy
4,134
+5
+0.1% +$810 0.31% 92
2021
Q4
$559K Buy
4,129
+14
+0.3% +$1.9K 0.25% 104
2021
Q3
$443K Hold
4,115
0.21% 120
2021
Q2
$464K Buy
4,115
+237
+6% +$26.7K 0.23% 113
2021
Q1
$439K Hold
3,878
0.22% 124
2020
Q4
$416K Sell
3,878
-391
-9% -$41.9K 0.25% 105
2020
Q3
$374K Sell
4,269
-191
-4% -$16.7K 0.24% 106
2020
Q2
$438K Buy
4,460
+1,008
+29% +$99K 0.31% 97
2020
Q1
$263K Sell
3,452
-593
-15% -$45.2K 0.23% 113
2019
Q4
$358K Buy
4,045
+308
+8% +$27.3K 0.24% 125
2019
Q3
$283K Sell
3,737
-538
-13% -$40.7K 0.2% 140
2019
Q2
$311K Buy
4,275
+454
+12% +$33K 0.21% 139
2019
Q1
$308K Buy
3,821
+561
+17% +$45.2K 0.22% 140
2018
Q4
$288K Buy
+3,260
New +$288K 0.24% 124